| P50 | author | Yves-Alain Barde | Q30106726 |
| | Nicholas Allen | Q58887759 |
| | Pedro Chacón-Fernández | Q89046192 |
| | Nicholas C Wu | Q39722696 |
| | Xinsheng Nan | Q40991312 |
| P2093 | author name string | Meng Li | |
| | Peter S DiStefano | |
| | Richard A Lerner | |
| | Jia Xie | |
| | Geramie Grande | |
| | Chih-Wei Lin | |
| | Alexey V Stepanov | |
| | Kate E Binley | |
| | Ronald M Lindsay | |
| | Spyros Merkouris | |
| P2860 | cites work | A de novo mutation affecting human TrkB associated with severe obesity and developmental delay | Q24307838 |
| | Activin A directs striatal projection neuron differentiation of human pluripotent stem cells | Q24324143 |
| | Identification of a novel mutation in the NTF4 gene that causes primary open-angle glaucoma in a Chinese population | Q24628693 |
| | Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis | Q24651301 |
| | Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma | Q24657994 |
| | Experimental observations on the development of polarity by hippocampal neurons in culture | Q24679532 |
| | Neurotrophin signal transduction in the nervous system | Q27876223 |
| | Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugates | Q28083123 |
| | Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses | Q28280944 |
| | Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids | Q28569805 |
| | The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 |
| | Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Q29615601 |
| | Mutation screen of the brain derived neurotrophic factor gene (BDNF): Identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder | Q57285564 |
| | Binding characteristics of brain-derived neurotrophic factor to its receptors on neurons from the chick embryo | Q69839044 |
| | Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease | Q72157868 |
| | A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III) | Q77398255 |
| | Upscaling of hiPS Cell-Derived Neurons for High-Throughput Screening | Q89351015 |
| | Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice | Q30486668 |
| | Short-term striatal gene expression responses to brain-derived neurotrophic factor are dependent on MEK and ERK activation | Q33434423 |
| | A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. | Q33664194 |
| | The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes | Q34013346 |
| | Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells | Q34036456 |
| | Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery | Q34060172 |
| | The neuroplasticity-associated arc gene is a direct transcriptional target of early growth response (Egr) transcription factors | Q34150847 |
| | Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor | Q34588700 |
| | Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates | Q34734974 |
| | Selecting agonists from single cells infected with combinatorial antibody libraries | Q34740000 |
| | A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease | Q35087700 |
| | Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease | Q35561386 |
| | Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects | Q35856484 |
| | Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy | Q36165553 |
| | Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. | Q36212795 |
| | FDA drug approval summary: panitumumab (Vectibix). | Q36830592 |
| | Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection | Q36959335 |
| | Up-regulation of brain-derived neurotrophic factor by application of fibroblast growth factor-2 to the cut optic nerve is important for long-term survival of retinal ganglion cells. | Q36984309 |
| | A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome | Q37008339 |
| | Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells. | Q37183432 |
| | A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease | Q37345118 |
| | Neurotrophin signalling: novel insights into mechanisms and pathophysiology | Q37629100 |
| | More Insight into BDNF against Neurodegeneration: Anti-Apoptosis, Anti-Oxidation, and Suppression of Autophagy. | Q37729120 |
| | Potential therapeutic uses of BDNF in neurological and psychiatric disorders | Q37848053 |
| | Pharmaceutical Characterization of Tropomyosin Receptor Kinase B-Agonistic Antibodies on Human Induced Pluripotent Stem (hiPS) Cell-Derived Neurons | Q38738325 |
| | Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next? | Q38804084 |
| | Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons. | Q38807798 |
| | Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons | Q38810200 |
| | Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors | Q39347922 |
| | An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma | Q39720313 |
| | Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities. | Q40232259 |
| | Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications. | Q40801545 |
| | Gadd45b is a novel mediator of neuronal apoptosis in ischemic stroke | Q41978642 |
| | Co-infusion with a TrkB-Fc receptor body carrier enhances BDNF distribution in the adult rat brain. | Q42060253 |
| | Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. | Q42471938 |
| | Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection | Q42497039 |
| | Brain-derived neurotrophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons | Q42499572 |
| | Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function | Q43148661 |
| | The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors | Q43735224 |
| | TrkB agonists ameliorate obesity and associated metabolic conditions in mice | Q46212129 |
| | Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. | Q47763741 |
| | Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists. | Q47791149 |
| | A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis | Q48686925 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E7023-E7032 | |
| P577 | publication date | 2018-07-09 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library | |
| P478 | volume | 115 | |